期刊文献+

人CRIF1基因调控骨髓间充质干细胞细胞周期分布初步研究

Primary study on the role of human CRIF1 gene in cell cycle regulation of bone marrow mesenchymal stem cells
下载PDF
导出
摘要 目的探讨人CRIF1基因对骨髓间充质干细胞(hBMSCs)细胞周期调控机制。方法通过构建慢病毒载体改变CRIF1表达水平,合成发夹shRNA模板寡核苷酸链,构建pGreenPuro-sh-CRIF1干扰载体;PCR扩增CRIF1基因CDS全长,链接pMD18-T载体经测序鉴定后,构建pLentis-CMV-CRIF1-SFFV-GTP过表达载体。载体成功构建后包装慢病毒,并转染hBMSCs,以pLentis-CMV-SFFV-GTP空载体病毒作为对照,定量PCR及Western blot(WB)检测CRIF1基因和蛋白表达,流式细胞仪检测hBMSCs细胞周期分布,并通过免疫荧光观察CRIF1与CDK2细胞共定位。结果成功构建CRIF1 shRNA及过表达慢病毒载体,测定后病毒滴度达到108TU/mL。以MOI=10转染hBMSCs,并以0.8μg/mL嘌呤霉素筛选1周后,感染效率可达到>95%,WB及定量PCR证实,CRIF1基因和蛋白的表达水平,在pGreenPuro-sh-CRIF1载体转染后hBMSCs细胞受到抑制:与对照组比较,mRNA相对表达水平0.42±0.03 vs1.00±0.03(P<0.01),蛋白相对表达水平0.13±0.024 vs 1.00±0.04(P<0.01),而pLentis-CMV-CRIF1-SFFV-GTP载体转染后得到增强:与对照组比较,mRNA相对表达水平5.54±0.53 vs 1.00±0.03(P<0.01),蛋白相对表达水平4.21±0.22 vs 1.00±0.04(P<0.01)。同时,CRIF1基因过表达诱导hBMSCs G0/G1期阻滞(与对照组比较,84.99±2.66 vs 77.28±0.86,P<0.01),抑制CRIF1基因表达促进其进入细胞周期循环:G0/G1期比例与对照组比较,61.60±3.02 vs 77.28±0.86(P<0.01)。激光共聚焦显示,CRIF1与CDK2共定位于胞浆与胞核。结论 CRIF1可能通过与CDK2结合,负性调控hBMSCs细胞周期分布。 Objective To study the function of human CRIF1 gene in cell cycle regulation of hBMSCs. Methods Hairpin siRNA template oligonucleotides and CRIF1 CDS were inserted into lentiviral vector pLentis-CMV-SFFV-GTP, and Plasmid DNA were verified by restriction enzyme analysis and DNA sequencing. Lentiviral vectors were eo-transfected to 293FT cells with pMD2. G and pSPAX2. Viral particles were harvested and then used for hBMSCs transfection. Expression of CRIF1 mRNA and protein were detected by qPCR and WB. Cell cycle of hBMSCs was analyzed by flow cytometry. Co-localization of CRIF1 and CDK2 was Observed by immunofluorescence. Results Lentiviral vectors were successfully constructed and named pGreenPuro-sh-CRIF1 and pLentis-CMV-CRIF1-SFFV-GTP respectively. The virus titer was 10s TU/mL. Recombinant lentivirus were transfected into hBMSCs (MOI = 10 ) and the efficiency of infection was above 95% after puromycin (0.8 μg/ mL) selection, qPCR and WB showed that expression of CRIF1 mRNA and protein were significantly higher (5.54 ± 0. 53 vs 1. 00±0. 03,4. 21±0. 22 vs 1.00 ± 0. 04 at the mRNA and protein level respectively, P 〈 0. 01 ) in pGreenPuro-sh-CRIF1 transfected h BMSCs and lower(0. 42 ±0. 03 vs 1.00± 0. 03,P 〈 0.01 ;0. 13 ±0. 024 vs 1. 00 ±0. 04 at the mRNA and protein tevel respectively, P 〈 0. 01 ) in pLentis-CMV-CRIF1-SFFV-GTP transfected hBMSCs when compared with control group. Also,increased expression of CRIF1 can make hBMSCs arrested in " G0/G1" phase compared with control group,84. 99 ±2. 66 vs 77. 28 ±0. 86, (P 〈0. 01 ) and impress the expression of CRIF1 to facilitate cell cycle GO/GI phase ratio 61.60 ± 3.02 vs 77. 28± 0. 86, (P 〈 0. 01 ). Confocal microscopy images showed a colocalization of CRIF1 and CDK2 in both cytoplasm and nucleus. Conclusion CRIF1 can negatively regulate hBMSCs proliferation by combining with CDK2.
出处 《中国输血杂志》 CAS CSCD 北大核心 2014年第5期484-488,共5页 Chinese Journal of Blood Transfusion
基金 国家自然科学基金(81102080)
关键词 CR6交互作用因子1 慢病毒 载体 骨髓间充质干细胞 细胞周期 基因表达 蛋白表达 白血病细胞 CR6-interacting factor 1 lentivirus vector BMSCs cell cycle gene expression protein expression
  • 相关文献

参考文献19

  • 1Tokcaer-Keskin Z, Akar AR, Ayaloglu-Butun F,el al. Timing of in- duction of cardiomyocyte differentiation for in vitro euhured mesen- chymal stem cells: a perspective for emergencies. Can J Physiol Pharmaco1,2009,87 ( 2 ) : 143-150.
  • 2Hu J, Feng K, I,iu X, el al. Chondrogenic aml ostengenic differentia- tions of human bone marrow-derived mesenchymal stem cells on a nanofibrous scaftbhl with designed pnre network. Biomaterials, 2009,30 ( 28 ) :5061-5067.
  • 3Chivu M,Dima SO,Stam.u Cl,el al. In vitro hepatic differentiation of human bone marrow mesenehymal slenl ceils under differential exposure to liver-specific factors. Transl Res, 2009,154 ( 3 ) : 122- 132.
  • 4Chu MS, Chang CF, Yang CC, et al. Signalling pathway in Ihe in- duction of neurile outgrowth in human mesenehymal stem cells. Cell Signal. 2006,18(4) :519-530.
  • 5赵智刚,孙立,张翼鷟,王晓芳,杨洪亮,陈智超,邹萍.骨髓增生异常综合征和急性髓细胞白血病骨髓间充质干细胞的病理学特征[J].临床血液学杂志,2010,23(6):671-674. 被引量:3
  • 6Pillozzi S, Masselli M, De Lorenzo E, el al. Chemotherapy resistance in acute lymphoblastic leukemia requires hERGI channels and is overcome by h E RG 1 blockers. Bhlood, 2011, 1 17 ( 3 ) : 902 -914.
  • 7Furuichi Y, Goi K, InJkai T,et al. Fins-like tyrosine kinase 3 ligand slimulalion induces MLL-reat-ranged leukemia cells into quiescence resistant to antileukemic agents. Cancer Res, 2007,67 ( 20 ) : 9852- 9861.
  • 8Dong-Feng Z,Ting L,Yong Z, et al. The TPO/c-MPL pathway in the bone marrow may protect leukemia cells from chemotherapy in AML Patients. Pathol Oncol Res. 2014,20(2) :309-317.
  • 9Chung HK, Yi YW, Jung NC, et al. CR6-interacting factor 1 inter- acts with Gadd45 family proteins and modulates the cell cycle. J Bi- ol Chem,2003,278 (30) :28079-28088.
  • 10李忠俊,陈幸华,滕本秀.白血病原代骨髓基质细胞对柔红霉素作用下Jurkat细胞基因表达的影响[J].中华血液学杂志,2006,27(5):327-330. 被引量:4

二级参考文献83

  • 1李忠俊,滕本秀,陈幸华,孔佩艳,王吉刚,彭贤贵,杨镇洲.白血病骨髓基质细胞对白血病细胞屏蔽效应的体外实验研究[J].癌症,2005,24(6):672-675. 被引量:9
  • 2李忠俊,陈幸华.白血病原代骨髓基质细胞诱导Jurkat细胞基因差异表达研究[J].第三军医大学学报,2006,28(14):1461-1463. 被引量:2
  • 3KOC O N,DAY J,NIEDER M,et al.Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPSIH)[J].Bone Marrow Transplantation,2002,30:215-222.
  • 4NOORT W A,KRUISSELBRINK A B,IN'T ANKER P S,et al.Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34 (+) cells in NOD/SCID mice[J].Exp Hematol,2002,30:870-878.
  • 5KOC O N,GERSON S L,COOPER B W,et al.Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy[J].J Clin Oncol,2000,18:307-316.
  • 6BHATIA R,MCGLAVE P B,DEWALD G W,et al.Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia:role of malignant stromal macrophages[J].Blood,1995,85:3636-3645.
  • 7Sangai T, Ishii G, Kodama K, et al. Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow-derived en- dothelial cells and myofibroblasts in cancer-induced stroma. Int J Cancer,2005.
  • 8Ellyard Jl, Avery DT, Mackay CR, et al. Contribution of stromal cells to the migration ,function and retention of plasma cells in hu- man spleen :potential roles of CXCL12, IL-6 and CD54. Eur J Im- munol,2005,35 ( 3 ) :699-708.
  • 9Balduino A, Hurtado SP, Frazao P, et al. Bone marrow subendosteal microenvironment harbours functionally distinct haemosupportive stromal cell populations. Cell Tissue Res, 2005,319 (2) : 255 -266.
  • 10Bradstoek KF, Gottlieb DJ. Interaction of acute leukemia cells with the bone marrow microenvironment : implications for control of mini- mal residual disease. Leuk Lymphoma,1995,18(1-2) :1-16.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部